LOGOLOGOLOGOLOGO
  • About us
    • Who we are
      • Governance
      • Staff
      • Vacancies
    • What we do
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Cell & Gene Therapies
      • Medicines For Rare Diseases And Children
      • Regulatory Efficiency
      • Biosimilars & Public Procurement
      • Data & Digital
      • Patient Bio-Forum
    • Industrial Biotechnology Council
      • Food, Feed & Nutrition
      • Circular Bioeconomy
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
  • Activities
    • 25 Years of Innovation
    • EFIB 2022
    • European Biotech Week
  • News & Events
    • News
    • Events
  • Library
Become a member
✕
  • 13/09/2023

    EU Industrial Forum report: Advanced Manufacturing at the heart of a resilient, sustainable and competitive Europe
  • 04/09/2023

    Factsheet – The Biotech Journey: From Bench to Patients
  • 11/08/2023

    SwiftPharma launches ‘Changing the global paradigm for biomanufacturing in plants’ October 23, Rotterdam
  • 28/07/2023

    EuropaBio position on the proposal for a Regulation on compulsory licensing for crisis management
  • 13/07/2023

    Reform of the EU General Pharmaceutical Legislation Joint Position Paper on the Hospital Exemption Scheme for ATMPs
  • 23/05/2023

    EuropaBio: Biomanufacturing and pharma legislation in the spotlight at the BIO International Convention 2023
  • 27/04/2023

    Celebrating bioeconomy and biotechnology on DNA Day and Earth Day
  • 26/04/2023

    EuropaBio welcomes the publication of the revision of the EU Pharmaceutical Legislation
  • 25/04/2023

    Europe’s Rare Disease SMEs raise their voice for success
  • 23/03/2023

    Unlocking the Potential of Biotechnology Innovation for Patients
  • 07/03/2023

    Disc Medicine joins EuropaBio: life-changing medicines for patients with hematologic disorders
  • 06/03/2023

    Can the Pharmaceutical Strategy Deliver for Europe?
  • 01/03/2023

    Vlad Olteanu new Healthcare Public Affairs Director at EuropaBio
  • 28/02/2023

    Helping Europe Deliver for Rare Disease Patients
  • 17/02/2023

    Do your best and do not forget, there will always be a next time!
  • 06/02/2023

    Delivering Europe’s ambitions in rare disease
  • 31/01/2023

    EuropaBio’s 2022 Patient BioForum sets out recommendations to address the challenges of patients with unmet medical needs and calls for multi-stakeholder approach
  • 19/12/2022

    The Association of Biotechnological Companies Bioforum joins EuropaBio: representing Polish biotech at European legislative fora and involving Polish companies in the debate about the future of the industry
  • 13/12/2022

    EuropaBio Principles for Genetic Testing and Testing for Genetically-Driven Risk Factor
  • 08/12/2022

    ‘Rare Disease Moonshot’ – Scaling-up public-private partnerships to accelerate research into world’s rarest diseases
123...10
Next page
LOGO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 2600 biotech companies, 2300 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2023 Europabio. All Rights Reserved. Designed by EYAS
Become a member